Compare VERU & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERU | CLIR |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8M | 33.4M |
| IPO Year | 1990 | 2012 |
| Metric | VERU | CLIR |
|---|---|---|
| Price | $2.19 | $0.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $25.00 | $2.00 |
| AVG Volume (30 Days) | ★ 174.8K | 110.8K |
| Earning Date | 12-17-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,153,000.00 |
| Revenue This Year | N/A | $13.13 |
| Revenue Next Year | N/A | $143.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.11 | $0.46 |
| 52 Week High | $14.20 | $1.72 |
| Indicator | VERU | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 38.29 |
| Support Level | $2.23 | $0.56 |
| Resistance Level | $2.49 | $0.65 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 10.91 | 10.76 |
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.